The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies
Open accessAbstract
Aims/hypothesis: The term prediabetes is used for individuals who have impaired glucose metabolism whose glucose or HbA 1c levels are not yet high enough to be diagnosed as diabetes. Prediabetes may already be associated with an increased risk of chronic ‘diabetes-related’ complications. This umbrella review aimed to provide a systematic overview of the available evidence from meta-analyses of prospective observational studies on the associations between prediabetes and incident diabetes-related complications in adults and to evaluate their strength and certainty. Methods: For this umbrella review, systematic reviews with meta-analyses reporting summary risk estimates for the associations between prediabetes (based on fasting or 2 h postload glucose or on HbA 1c) and incidence of diabetes-related complications, comorbidities and mortality risk were included. PubMed, Web of Science, the Cochrane Library and Epistemonikos were searched up to 17 June 2021. Summary risk estimates were recalculated using a random effects model. The certainty of evidence was evaluated by applying the GRADE tool. This study is registered with PROSPERO, CRD42020153227. Results: Ninety-five meta-analyses from 16 publications were identified. In the general population, prediabetes was associated with a 6–101% increased risk for all-cause mortality and the incidence of cardiovascular outcomes, CHD, stroke, heart failure, atrial fibrillation and chronic kidney disease, as well as total cancer, total liver cancer, hepatocellular carcinoma, breast cancer and all-cause dementia with moderate certainty of evidence. No associations between prediabetes and incident depressive symptoms and cognitive impairment were observed (with low or very low certainty of evidence). The association with all-cause mortality was stronger for prediabetes defined by impaired glucose tolerance than for prediabetes defined by HbA 1c. Conclusions/interpretation: Prediabetes was positively associated with risk of all-cause mortality and the incidence of cardiovascular outcomes, CHD, stroke, chronic kidney disease, cancer and dementia. Further high-quality studies, particularly on HbA 1c-defined prediabetes and other relevant health outcomes (e. g. neuropathy) are required to support the evidence. Graphical abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
Self-citationAromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000055 · Cited by 2,587 · cited 1×
“In this context, umbrella reviews are helpful tools because they provide a broad overview of the existing evidence by focusing on published systematic reviews with meta-analyses on a specific topic and enable evaluation of the certainty of evidence and the risk of bias of the published meta-analyses [16].”
BackgroundROBIS: A new tool to assess risk of bias in systematic reviews was developed
Whiting, P., Savović, J., Higgins, J. P. T., Caldwell, D. M., Reeves, B. C., Shea, B., Davies, P., Kleijnen, J., & Churchill, R. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.06.005 · Cited by 2,272
Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013
Wang, L., Gao, P., Zhang, M., Huang, Z., Zhang, D., Deng, Q., Li, Y., Zhao, Z., Qin, X., Jin, D., et al. (2017) · JAMA · doi:10.1001/jama.2017.7596 · Cited by 1,844
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Self-citationHuang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016) · BMJ · doi:10.1136/bmj.i5953 · Cited by 1,012 · cited 2×
“The methodological quality was rated as low risk of bias for four reports [7, 8, 29, 34] and high risk of bias for the remaining reports.”
BackgroundType 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 860
Cai, X., Zhang, Y., Li, M., Wu, J. H., Mai, L., Li, J., Yang, Y., Hu, Y., & Huang, Y. (2020) · BMJ · doi:10.1136/bmj.m2297 · Cited by 749
Xue, M., Xu, W., Ou, Y.-N., Cao, X.-P., Tan, M.-S., Tan, L., & Yu, J.-T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100944 · Cited by 715 · cited 3×
“Mental/cognitive disorders Depressive symptoms [28] Depressive symptoms [28] All-cause dementia [9]b All-cause dementia [9]b All-cause dementia [9]b Alzheimer's dementia [9]b Vascular dementia [9]b Cognitive impairment [9]b .”
BackgroundChatterjee, S., Peters, S. A. E., Woodward, M., Mejia Arango, S., Batty, G. D., Beckett, N., Beiser, A., Borenstein, A. R., Crane, P. K., Haan, M., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1588 · Cited by 711
Gong, Q., Zhang, P., Wang, J., Ma, J., An, Y., Chen, Y., Zhang, B., Feng, X., Li, H., Chen, X., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30093-2 · Cited by 615
Gregg, E. W., Cheng, Y. J., Srinivasan, M., Lin, J., Geiss, L. S., Albright, A. L., & Imperatore, G. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30314-3 · Cited by 480
Haw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354
Glycemic Thresholds for Diabetes-Specific Retinopathy
Colagiuri, S., Lee, C. M. Y., Wong, T. Y., Balkau, B., Shaw, J. E., Borch-Johnsen, K., & the DETECT-2 Collaboration Writing Group (2011) · Diabetes Care · doi:10.2337/dc10-1206 · Cited by 300
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 283
Using systematic reviews in guideline development: The GRADE approach
Zhang, Y., Akl, E. A., & Schünemann, H. J. (2019) · Research Synthesis Methods · doi:10.1002/jrsm.1313 · Cited by 260 · cited 1×
“Certainty of evidence The certainty of evidence was evaluated by two authors independently using the GRADE tool [22].”
MethodPrediabetes and the risk of cancer: a meta-analysis
Huang, Y., Cai, X., Qiu, M., Chen, P., Tang, H., Hu, Y., & Huang, Y. (2014) · Diabetologia · doi:10.1007/s00125-014-3361-2 · Cited by 234
Aune, D., Feng, T., Schlesinger, S., Janszky, I., Norat, T., & Riboli, E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.02.004 · Cited by 234
Self-citationShen, Y., Cai, R., Sun, J., Dong, X., Huang, R., Tian, S., & Wang, S. (2017) · Endocrine · doi:10.1007/s12020-016-1014-6 · Cited by 230
Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies
Rotella, F., & Mannucci, E. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.11.022 · Cited by 226
Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy
Bönhof, G. J., Herder, C., Strom, A., Papanas, N., Roden, M., & Ziegler, D. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00107 · Cited by 221
Self-citationWang, Y., O’Neil, A., Jiao, Y., Wang, L., Huang, J., Lan, Y., Zhu, Y., & Yu, C. (2019) · BMC Medicine · doi:10.1186/s12916-019-1355-0 · Cited by 207
Chen, Y., Wu, F., Saito, E., Lin, Y., Song, M., Luu, H. N., Gupta, P. C., Sawada, N., Tamakoshi, A., Shu, X.-O., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4229-z · Cited by 206
Prediabetes and the risk of heart failure: A meta‐analysis
Cai, X., Liu, X., Sun, L., He, Y., Zheng, S., Zhang, Y., & Huang, Y. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14388 · Cited by 159
Echouffo-Tcheugui, J. B., Narayan, K. M. V., Weisman, D., Golden, S. H., & Jaar, B. G. (2016) · Diabetic Medicine · doi:10.1111/dme.13113 · Cited by 158
Cheng, Y. J., Imperatore, G., Geiss, L. S., Saydah, S., Albright, A. L., Ali, M. K., & Gregg, E. W. (2018) · Diabetes Care · doi:10.2337/dc18-0831 · Cited by 134
Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta‐Analysis
Mitsios, J. P., Ekinci, E. I., Mitsios, G. P., Churilov, L. P., & Thijs, V. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007858 · Cited by 128
Prevalence of peripheral neuropathy in pre-diabetes: a systematic review
Kirthi, V., Perumbalath, A., Brown, E. E., Nevitt, S. J., Petropoulos, I. N., Burgess, J., Roylance, R., Cuthbertson, D. J., Jackson, T. L., Malik, R. A., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002040 · Cited by 121
Aune, D., Schlesinger, S., Norat, T., & Ríboli, E. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.02.011 · Cited by 117
Self-citationPalladino, R., Tabak, A. G., Khunti, K., Valabhji, J., Majeed, A., Millett, C., & Vamos, E. P. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001061 · Cited by 98
Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
and the DPP Research Group, Nathan, D. M., Bennett, P. H., Crandall, J. P., Edelstein, S. L., Goldberg, R. B., Kahn, S. E., Knowler, W. C., Mather, K. J., Mudaliar, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4928-8 · Cited by 91
Lamparter, J., Raum, P., Pfeiffer, N., Pető, T., Höhn, R., Elflein, H. M., Wild, P. S., Schulz, A., Schneider, A., & Mirshahi, A. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.02.008 · Cited by 88
An investigation of causal relationships between prediabetes and vascular complications
Mutie, P. M., Pomares‐Millan, H., Atabaki‐Pasdar, N., Jordan, N., Adams, R., Daly, N. L., Tajes, J. F., Giordano, G. N., & Franks, P. W. (2020) · Nature Communications · doi:10.1038/s41467-020-18386-9 · Cited by 85
The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review
Eleftheriadou, A., Williams, S., Nevitt, S. J., Brown, E. E., Roylance, R., Wilding, J. P. H., Cuthbertson, D. J., & Alam, U. (2020) · Diabetologia · doi:10.1007/s00125-020-05316-z · Cited by 80
Bougioukas, K. I., Bouras, E., Apostolidou‐Kiouti, F., Kokkali, S., Arvanitidou, M., & Haidich, A. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.10.005 · Cited by 58
Herder, C., Roden, M., & Ziegler, D. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.02.007 · Cited by 51
Self-citationPan, Y., Chen, W., & Wang, Y. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.11.008 · Cited by 49
Ball, J., Løchen, M., Wilsgaard, T., Schirmer, H., Hopstock, L. A., Morseth, B., Mathiesen, E. B., Njølstad, I., Tiwari, S., & Sharashova, E. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008414 · Cited by 47
Kowall, B., Rathmann, W., Heier, M., Holle, R., Peters, A., Thorand, B., Herder, C., Straßburger, K., Giani, G., & Meisinger, C. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.161 · Cited by 39
Self-citationTong, A., Wang, X., Li, F., Xu, F., Li, Q., & Zhang, F. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0845-1 · Cited by 34
Fizelova, M., Stančáková, A., Lorenzo, C., Haffner, S. M., Cederberg, H., Kuusisto, J., & Laakso, M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4121 · Cited by 21
Zhao, Y., Guo, M., & Shi, G. (2019) · Bioscience Reports · doi:10.1042/bsr20193130 · Cited by 17
Li, Y., Li, X.-W., Zhang, Y., Zhang, L., Wu, Q., Bai, Z., Jin, S., Zuo, X.-B., Shi, N., Li, J., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001029 · Cited by 11
The effect of prediabetes on hepatocellular carcinoma risk: a systematic review and meta-analysis
Xu, W., Qian, Y.-F., & Wu, J. (2017) · Minerva Medica · doi:10.23736/s0026-4806.16.04601-2 · Cited by 10
Cited by
Stefan, N., & Schulze, M. B. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00086-4 · Cited by 215
Sandforth, A., von Schwartzenberg, R. J., Arreola, E. V., Hanson, R. L., Sancar, G., Katzenstein, S., Lange, K., Preißl, H., Dreher, S. I., Weigert, C., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00235-8 · Cited by 100
Self-citationThe Effectiveness of Metformin in Diabetes Prevention: A Systematic Review and Meta-Analysis
Patel, D., Ayesha, I. E., Monson, N. R., Klair, N., Patel, U., Saxena, A., & Hamid, P. (2023) · Cureus · doi:10.7759/cureus.46108 · Cited by 29
Metadata
- Authors
- Schlesinger, S., Neuenschwander, M., Barbaresko, J., Lang, A., Maalmi, H., Rathmann, W., Roden, M., & Herder, C.
- Venue
- Diabetologia
- Published
- 2021-10-31
- Volume
- 65
- Issue
- 2
- Pages
- 275-285
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W3210126550
- Cited by
- 327
- References
- 48
- FWCI
- 30.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.